Innovent and Eli Lilly’s trial of TYVYT meets primary endpoint
The ORIENT-12 Phase III trial evaluated TYVYT, Gemzar and platinum chemotherapy combination to treat metastatic squamous non-small cell lung cancer. Credit: Nephron.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more